Retatrutide is a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By activating these https://leaerzv430887.getblogs.net/68757748/tirzepatide-a-promising-new-treatment-for-obesity